Dr Jaffar Khan (National Heart, Lung and Blood Institute, Washington, DC, US) discusses the latest results from the BASILICA trial and the prevention of coronary artery obstruction from TAVR. 

Filmed on-site at CRT 2019 by Radcliffe Cardiology.

Questions:

1. Why did you perform this feasibility study?

2. What was the study design and the endpoints?

3. What were your findings?

Videographer: Tom Green

Educational Lead: Liam O'Neill, Chief Operating Officer